DrugCentral 2018: An update

Nucleic Acids Research

Volumn 47, Issue D1, 2019, Pages D963-D970

  Ursu, Oleg ^a   Holmes, Jayme ^a   Bologa, Cristian G ^a   Yang, Jeremy J ^a   Mathias, Stephen L ^a   Stathias, Vasileios ^b   Nguyen, Dac Trung ^c   Schürer, Stephan ^b   Oprea, Tudor ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c National Center for Advancing Translational Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENRALIZUMAB; BRODALUMAB; CENEGERMIN; COPANLISIB; DUPILUMAB; ELOBIXIBAT; ENASIDENIB; FORODESINE; INOTUZUMAB OZOGAMICIN; TELOTRISTAT ETHYL; DRUG; PROTEIN;

ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG DATABASE; DRUG FORMULATION; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; TREND STUDY; ADVERSE DRUG REACTION; CLASSIFICATION; DRUG APPROVAL; DRUG EFFECT; GENE EXPRESSION;

DATABASES, PHARMACEUTICAL; DRUG APPROVAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GENE EXPRESSION; PHARMACEUTICAL PREPARATIONS; PROTEINS;

EID: 85059796300     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gky963     Document Type: Article

References (21)

1. Ursu, O., Holmes, J., Knockel, J., Bologa, C.G., Yang, J.J., Mathias, S.L., Nelson, S.J. and Oprea, T.I. (2017) DrugCentral: online drug compendium. Nucleic Acids Res., 45, gkw993.
2. Gaulton, A., Hersey, A., Nowotka, M., Bento, A.P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L.J., Cibrián-Uhalte, E. et al. (2017) The ChEMBL database in 2017. Nucleic Acids Res., 45, D945-D954.
3. Hastings, J., Owen, G., Dekker, A., Ennis, M., Kale, N., Muthukrishnan, V., Turner, S., Swainston, N., Mendes, P. and Steinbeck, C. (2016) ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res., 44, D1214-D1219.
4. Kim, S., Thiessen, P.A., Bolton, E.E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B.A. et al. (2016) PubChem substance and compound databases. Nucleic Acids Res., 44, D1202-D1213.
5. Skuta, C., Popr, M., Muller, T., Jindrich, J., Kahle, M., Sedlak, D., Svozil, D. and Bartunek, P. (2017) Probes & Drugs portal: an interactive, open data resource for chemical biology. Nat. Methods, 14, 759-760.
6. Nguyen, D.-T., Mathias, S., Bologa, C., Brunak, S., Fernandez, N., Gaulton, A., Hersey, A., Holmes, J., Jensen, L.J., Karlsson, A. et al. (2016) Pharos: Collating protein information to shed light on the druggable genome. Nucleic Acids Res., 45, 1-8.
7. Brown, A.S. and Patel, C.J. (2017) A standard database for drug repositioning. Sci. Data, 4, 170029.
8. Santos, R., Ursu, O., Gaulton, A., Bento, A.P., Donadi, R.S., Bologa, C.G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T.I. et al. (2016) A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov., 16, 19-34.
9. Subramanian, A., Narayan, R., Corsello, S.M., Peck, D.D., Natoli, T.E., Lu, X., Gould, J., Davis, J.F., Tubelli, A.A., Asiedu, J.K. et al. (2017) A next generation connectivity Map: L1000 platform and the first 1,000,000 profiles. Cell, 171, 1437-1452.
10. Milletti, F., Storchi, L., Goracci, L., Bendels, S., Wagner, B., Kansy, M. and Cruciani, G. (2010) Extending pKa prediction accuracy: High-throughput pK a measurements to understand pKa modulation of new chemical series. Eur. J. Med. Chem., 45, 4270-4279.
11. Wishart, D.S., Feunang, Y.D., Guo, A.C., Lo, E.J., Marcu, A., Grant, J.R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z. et al. (2017) DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res., 46, D1074-D1082.
12. Chambers, J., Davies, M., Gaulton, A., Hersey, A., Velankar, S., Petryszak, R., Hastings, J., Bellis, L., McGlinchey, S. and Overington, J.P. (2013) UniChem: A unified chemical structure cross-referencing and identifier tracking system. J. Cheminform., 5, 3.
13. Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. and Morishima, K. (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res., 45, D353-D361.
14. Harding, S.D., Sharman, J.L., Faccenda, E., Southan, C., Pawson, A.J., Ireland, S., Gray, A.J.G., Bruce, L., Alexander, S.P.H., Anderton, S. et al. (2018) The IUPHAR/BPS Guide to Pharmacology in 2018: Updates and expansion to encompass the new guide to immunopharmacology. Nucleic Acids Res., 46, D1091-D1106.
15. Roth, B.L., Lopez, E., Patel, S. and Kroeze, W.K. (2000) The multiplicity of serotonin receptors: Uselessly diverse molecules or an embarrassment of riches? Neurosci., 6, 252-262.
16. Oprea, T.I., Bologa, C.G., Brunak, S., Campbell, A., Gan, G.N., Gaulton, A., Gomez, S.M., Guha, R., Hersey, A., Holmes, J. et al. (2018) Unexplored therapeutic opportunities in the human genome. Nat. Rev. Drug Discov., 17, 317-332.
17. Valentin, J.-P. and Hammond, T. (2008) Safety and secondary pharmacology: Successes, threats, challenges and opportunities. J. Pharmacol. Toxicol. Methods, 58, 77-87.
18. Nelson, S.J. (2009) Medical terminologies that work: the example of MeSH. In: 2009 10th Int. Symp. Pervasive Syst. Algorithms, Networks. IEEE, Kaohsiung.
19. Pihan, E., Colliandre, L., Guichou, J.-F. and Douguet, D. (2012) e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics, 28, 1540-1541.
20. Huang, L., Zalkikar, J. and Tiwari, R.C. (2011) A likelihood ratio test based method for signal detection with application to FDA's drug safety data. J. Am. Stat. Assoc., 106, 1230-1241.
21. Manallack, D.T., Prankerd, R.J., Yuriev, E., Oprea, T.I. and Chalmers, D.K. (2013) The significance of acid/base properties in drug discovery. Chem. Soc. Rev., 42, 485-496.